Drugs / IMC-TR1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01646203 | Jul 2012 → Oct 2014 | neoplasm | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IMC-TR1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01646203 ↗ |